News | SCAI | May 01, 2024

Groundbreaking Data in Interventional Cardiology to be Featured at Society for Cardiovascular Angiology and Interventions SCAI 2024 Scientific Sessions

The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine for late-breaking science on PCI, TAVR, PAD and heart valve studies.

The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine.

The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine. Image courtesy: Long Beach Convention Center


May 1, 2024 — The annual Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, and organizers report the annual meeting will bring together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine.

“We are proud to offer over 80 sessions in a variety of interactive educational formats at this year’s meeting. We believe the tools, resources, and information shared at the meeting will provide the healthcare community with greater expertise to improve patient outcomes and also connect with their interventional cardiology colleagues,” said SCAI President George D. Dangas, MD, PhD, MSCAI, Icahn School of Medicine - Mt. Sinai Hospital (New York, NY).

Presenting the latest cutting-edge advances in cardiovascular research, prevention, and care will be 500+ faculty, nearly 450 abstracts presenting the latest clinical data, procedural guidance, and advanced expertise, according to the organization, which offered the following snapshot summary.

Heart disease has been the leading cause of death in the United States since 1950, and as one of the most prevalent health conditions, impacting half of all Americans. According to the Centers for Disease Control and Prevention (CDC), heart disease and stroke rank as the first and fifth leading causes of death in the nation. These conditions affect millions of individuals across the country each year, with more than 877,500 Americans experiencing symptoms related to heart disease, stroke, or other cardiovascular diseases annually. This prevalence underscores the urgent need for heightened awareness, prevention strategies, and access to quality healthcare services to combat the detrimental effects of cardiovascular diseases on public health.

“At this year’s SCAI Scientific Sessions, we are seeing a broad range of clinical trials and emerging science all with the same aim – improving patient outcomes and experience. Featuring numerous abstracts with fresh insights into health disparities, efficacy data for TAVR, and innovative strategies for PAD, we eagerly anticipate the convergence of professionals from diverse specialties. Their teamwork and collaboration, allows us to advance collective efforts within this sector, driving forward innovation and enhancing patient care," said SCAI Interventional Cardiology Program Chair, J. Dawn Abbott, MD, FSCAI, Lifespan Cardiovascular Institute.     

Late-Breaking Cardiovascular Clinical Trials: PCI, TAVR, PAD in the Spotlight

New Research: As a common non-surgical procedure used to treat blockages in a coronary artery, around 900,000 percutaneous coronary interventions (PCIs) are performed every year in the U.S. This new study looks at the trends and clinical outcomes with radial versus femoral arterial access for PCIs.

Late-breaking oral presentation: Temporal Trends and Clinical Outcomes with Radial Versus Femoral Arterial Access for Percutaneous Coronary Intervention in the US (Date and Time: Thursday, May 2 9:17-9:24 AM PT)

Transcatheter Aortic Valve Replacement (TAVR): TAVR is a minimally-invasive procedure to replace an aortic valve that is narrowed and doesn't open fully, which can help reduce chest pain, shortness of breath and other symptoms of aortic valve stenosis. About 276,000 patients have undergone a TAVR procedure in the United States. This year’s meetings will feature presentations focusing on TAVR including:

Late-breaking oral presentation: Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valve Replacement in Patients with Small Aortic Annuli: Additional Outcomes from the SMART Trial (Date and Time: Friday, May 3 2:44-2:51 PM PT)

Late-breaking oral presentation: Self Update from the First-in-human study with the novel DurAVR biomimetic transcatheter heart valve (Date and Time: Friday, May 3 10:55-11:00 AM PT)

Peripheral Artery Disease (PAD): According to a recent survey, 70% of Americans are unaware of PAD – the most common vascular disease in which leg arteries become narrowed, reducing or cutting off blood flow. PAD contributes to 400 amputations each day.

This year’s meetings will feature several studies addressing PAD including:

Late-breaking oral presentation: Revascularization strategies in patients with peripheral arterial disease involving the femoropopliteal arteries: A pooled analysis of individual patient data (Date and Time: Friday, May 3:12-3:19 PM PT)

More information: www.scai.org

Find more SCAI24 conference coverage here

 


Related Content

News | Cardiovascular Education

May 31, 2024 — In the United States there are over 8 million active athletes. Given the rapid expansion of sports ...

Home May 31, 2024
Home
News | Cardiovascular Education

April 25, 2024 —Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from ...

Home April 25, 2024
Home
News | Cardiovascular Education

March 21, 2024 — The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of ...

Home March 21, 2024
Home
Feature | Cardiovascular Education | Christine Book

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country ...

Home February 01, 2024
Home
News | Cardiovascular Education

January 15, 2024 — A public-private partnership Think Tank, scheduled for Feb. 29-March 1, will be presented by the ...

Home January 15, 2024
Home
News | Cardiovascular Education

December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

Home December 04, 2023
Home
News | Cardiovascular Education

October 5, 2023 — The 2023 American College of Cardiology (ACC) Quality Summit kicks off on October 11-13 in Orlando ...

Home October 05, 2023
Home
News | Cardiovascular Education

DAIC’s award-winning editorial team delivers industry trends and technology information to the professionals who make ...

Home August 16, 2023
Home
Feature | Cardiovascular Education | Christine Book

May 4, 2023 — A new book on a broad collection of cases, led by a team of investigators from the Smidt Heart Institute ...

Home May 04, 2023
Home
News | Cardiovascular Education

April 10, 2023 — Viatris Inc., a global healthcare company, and the American College of Cardiology (ACC) today released ...

Home April 10, 2023
Home
Subscribe Now